Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening

John Forman1, Fiona Coyle, Jill Levy-Fisch

  • 1New Zealand Organisation for Rare Disorders (NZORD), PO Box 38-538, Wellington Mail Centre, 5045, Wellington, New Zealand, exec.director@nzord.org.nz.

Insights

Newborn metabolic screening effectively identifies genetic disorders but lacks consensus on screened conditions. Criteria should evolve to include family and societal values for better ethical decision-making.

Area of Science:

  • Medical Genetics
  • Public Health
  • Bioethics

Background:

  • Newborn metabolic screening, utilizing Guthrie cards, is a widespread genetic health service screening nearly all newborns for metabolic diseases.
  • Despite its long history and benefits, there's a lack of consensus on which conditions to screen for and how to adapt to medical advancements.

Purpose of the Study:

  • To evaluate international criteria for newborn metabolic screening.
  • To highlight the inadequacies of current criteria concerning the baby, family, and society.
  • To propose an improved framework for screening criteria development.

Main Methods:

  • Analysis of international criteria for newborn metabolic screening.
  • Examination of ethical considerations in screening criteria.
  • Assessment of the influence of family and societal values on screening panel decisions.

Main Results:

  • International criteria for newborn metabolic screening are poorly developed regarding the broader impact on individuals and society.
  • Ethical considerations are often underdeveloped, hindering consensus on screening criteria.
  • Family and societal values significantly influence screening panel composition, with responsive programs incorporating these elements.

Conclusions:

  • Current newborn metabolic screening criteria require significant adaptation.
  • Decision criteria should be revised to incorporate parent/family interests, community values, patient rights, and ethical considerations.
  • A more inclusive approach is needed for effective and ethical newborn screening programs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare: